Literature DB >> 10727209

Identification of 12-lipoxygenase interaction with cellular proteins by yeast two-hybrid screening.

K Tang1, R L Finley, D Nie, K V Honn.   

Abstract

The platelet isoform of 12-lipoxygenase (12-LOX) is expressed in a variety of human tumors. 12-LOX metabolizes arachidonic acid to 12(S)-hydroxyeicosateraenoic acid (12(S)-HETE), which induces a number of cellular responses associated with tumor progression and metastasis. Little is known about 12-LOX regulation and no direct regulators of 12-LOX activity have been identified. To identify potential regulators of 12-LOX, we isolated cDNAs encoding 12-LOX interacting proteins using the yeast two-hybrid system. We screened a yeast two-hybrid interaction library from human epidermoid carcinoma A431 cells and identified four cellular proteins that interact specifically with 12-LOX. We identified type II keratin 5, lamin A, the cytoplasmic domain of integrin beta4 subunit and a phosphoprotein C8FW as 12-LOX interacting proteins. Here, we demonstrated that keratin 5, a 58 kD protein required for formation of 8 nm intermediate filaments, binds to 12-LOX in human tumor cells and may contribute to the regulated trafficking of 12-LOX. We also showed that lamin A binds 12-LOX in human tumor cells. These proteins provide the first candidate regulators of 12-LOX.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727209     DOI: 10.1021/bi992664v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  TRB3: an oxidant stress-induced pseudokinase with a potential to negatively modulate MCP-1 cytokine in diabetic nephropathy.

Authors:  Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-25

Review 2.  Lamin-binding Proteins.

Authors:  Katherine L Wilson; Roland Foisner
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-17       Impact factor: 10.005

Review 3.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

4.  Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells.

Authors:  Bo Yin; Yang Yang; Zhiqiang Zhao; Yu Zeng; Steven M Mooney; Ming Li; Xuewen Xu; Yongsheng Song; Bin Wu; Zhibo Yang
Journal:  Int J Oncol       Date:  2011-01-11       Impact factor: 5.650

5.  Convergence of eicosanoid and integrin biology: Role of Src in 12-LOX activation.

Authors:  Ashok-Kumar Dilly; Keqin Tang; Yande Guo; Sangeeta Joshi; Prasanna Ekambaram; Krishna Rao Maddipati; Yinlong Cai; Stephanie C Tucker; Kenneth V Honn
Journal:  Exp Cell Res       Date:  2016-12-20       Impact factor: 3.905

6.  Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality.

Authors:  M Hesse; T Franz; Y Tamai; M M Taketo; T M Magin
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

7.  15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.

Authors:  Hong Zhu; Wayne Glasgow; Margaret D George; Kali Chrysovergis; Kenneth Olden; John D Roberts; Thomas Eling
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

Review 8.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

9.  Non-synonymous polymorphism (Gln261Arg) of 12-lipoxygenase in colorectal and thyroid cancers.

Authors:  Vidudala V T S Prasad; Kolli Padma
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

10.  Identification of a novel muscle A-type lamin-interacting protein (MLIP).

Authors:  Elmira Ahmady; Shelley A Deeke; Seham Rabaa; Lara Kouri; Laura Kenney; Alexandre F R Stewart; Patrick G Burgon
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.